title: Second National Immunization Congress 2010: addressing vaccine financing for the future in the US.
abstract: At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors--manufacturers, providers, public health, employers, payors, insurers, and consumers--will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.
authors.affiliation: National Vaccine Program Office US Department of Health and Human Services, Washington, DC, USA. angela.shen@hhs.gov
authors.forename: Angela K
authors.initials: AK
authors.lastname: Shen
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Sobzcyk
authors.forename: Anna
authors.initials: A
authors.lastname: Buchanan
authors.forename: Lauren
authors.initials: L
authors.lastname: Wu
authors.forename: Sarah
authors.initials: S
authors.lastname: Duggan-Goldstein
mesh_terms: D003141:Communicable Diseases / Q000453:epidemiology; D006291:Health Policy; D006801:Humans; D055818:Public-Private Sector Partnerships / Q000639:trends; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000191:economics* / Q000639:trends*; D014612:Vaccines / Q000191:economics* / Q000276:immunology*
chemical_list: D014612:Vaccines